Marc Beer and Renovia Inc.December 24, 2018 - Author: steph
Marc Beer is an entrepreneur who founded the Renovia, Inc. Renovia is a pharmaceutical company that specializes in researching women’s disorders. They not only research women’s disorders but they also develop medications to fight these disorders. Marc Beer is the co-founder, and he is the current Chairman and CEO (Chief Operating Officer) of Renovia.
Before Marc became the CEO of Renovia, he worked in other various pharmaceutical companies. Beer brought 25 years of experience to the table when he founded Renovia. He is a college graduate. Marc graduated with a Bachelor’s of Science from the University of Miami. He attended the Oxford, Ohio campus.
Renovia recently developed a drug for treating pelvic floor disorders in women.
Women suffer from pelvic floor disorders worldwide. The drug, Leva, will be on the market soon. Leva is designed to help treat women with pelvic floor disorders who suffer from urinary incontinence.
The World Health Organization (WHO) estimates there are over 250 million women worldwide who suffer from pelvic floor disorders. Beer recently raised $42 million for further research of women’s health issues. The medication to treat pelvic floor disorders in women will be available on the market soon. The FDA (Food and Drug Administration) approved the drug for marketing in April 2018.
Marc Beer is a man of experience. He worked in the field of pharmaceuticals and research for many years before becoming the co-founder of Renovia. He co-founded Renovia with Ramon Iglesias MD and Yolanda Lorie. He brought 25 years experience to the table. The other two co-founders also brought some background to the table. Together, they make an excellent team to do research and develop new medications.
Beer and his team at Renovia will be putting the $42 million to work for them. They intend on doing further research not only into pelvic floor disorders but also other women’s health issues. It is crucial to the enhancement of Renovia that the team further its research on the subject of women’s health.
The team began Renovia in August 2016. They successfully closed a Plan A funding source from venture capitalists. After the approval of Leva, they closed the Plan B funding source from the venture capitalists. They closed $32 million on Plan B. The also raised an additional $10 million for their research efforts.
In conclusion, this article discussed Marc Beer. We talked about the co-founding of Renovia. We discussed his partners and education. Also, detailed were his raising funds for Renovia. The funds will assist the team at Renovia in further researching women’s health issues. The team has already developed one new drug to combat pelvic floor disorders. They intend to create more drugs shortly. They began in their research in 2016. Learn more: https://renoviainc.com/leadership/